ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

sulthiame

Its studies are mostly in Renal Insufficiency · Sleep Apnea, Obstructive, led by 2 companies.

Drug pageSulthiame: every studyAll 3 studies of it, academic ones too, with its approvals, label and forms.
Furthest: phase 2, since Jan 20, 20222 company-led studies, 1 open or runningNext primary completion: Dec 4, 2026 (phase 1)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Desitin Arzneimittelits history only10 open or runningphase 2since Jan 20, 2022Jan 20, 2022none ahead
Shionogiits history only11 open or runningphase 1since Sep 29, 2026Sep 29, 2026Dec 4, 2026phase 1 · NCT07857837

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and studies of every company. Pick one to see its own:

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Jan 20, 2022First study: phase 2 study in Sleep Apnea, ObstructiveNew to Desitin ArzneimittelDesitin Arzneimittel · NCT05236842 · 298 enrolled · Belgium
  2. Sep 29, 2026Shionogi’s first study: phase 1 study in Renal InsufficiencyNew to ShionogiShionogi · NCT07857837 · 30 planned · United States

Ahead

  1. Dec 4, 2026Primary completion: phase 1 study in Renal InsufficiencyShionogi · NCT07857837

TargetBeta

“Carbonic anhydrase inhibitor”ChEMBL 37, by rule

Studies

All 2 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusLed byPrimary completionSize
NCT07857837Renal Insufficiency · United States1Not yet recruitingShionogiDec 4, 202630
NCT05236842Sleep Apnea, Obstructive · Belgium2CompletedDesitin ArzneimittelAug 15, 2023298

How it is read

Names in the registry

  • “Sulthiame”, 2 entries

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.